Match Document Document Title
US20110002989 METHODS, DOSAGE FORMS AND KITS FOR ADMINISTERING ZIPRASIDONE WITHOUT FOOD  
The present invention provides methods, dosage forms and kits for treating with an effective amount of ziprasidone a CNS disorder in a human when the human is in a fasted state. In one embodiment,...
US20140308293 RECONSTITUTION METHOD FOR HIGH CONCENTRATION DRY PROTEIN FORMULATIONS  
The present invention relates to the provision of a novel method for the reconstitution of dry formulations comprising biomolecules, and in particular, to dry protein formulations, and to...
US20130172291 RETINAL CYCLODEXTRIN ACETALS AND HEMIACETALS FOR TREATING SKIN COMPLEXION DISORDER  
The present invention discloses certain polyene cyclodextrin acetals and hemiacetals that are effective in providing skin clarification, which is useful for the treatment of acne, and skin...
US20120289479 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and Cholesterol  
This invention is based in part on the elucidation of new structural conformations and functions of the sodium/potassium adenosine triphosphate synthase (Na/K ATPase), and especially elucidation...
US20140228318 Curcumin formulations and methods for making such formulations  
The present invention provides cyclodextrin-curcumin inclusion complexes, self-assemblies thereof; methods for making such inclusion complexes and self-assemblies, and methods for their use.
US20130123214 USE OF DELTA TOCOPHEROL FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS  
This disclosure relates generally to the treatment of lysosomal storage disorders. Specifically, the disclosure relates to a novel use of delta tocopherol in the treatment of diseases and...
US20140107067 COMPOSITIONS COMPRISING DIETARY FAT COMPLEXERS AND METHODS FOR THEIR USE  
This invention relates to fat containing consumable food products comprising α-cyclodextrin. The food products have reduced levels of bioavailable fat but have substantially the same fat,...
US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use  
This invention relates to fat containing consumable food products comprising α-cyclodextrin. The food products have reduced levels of bioavailable fat but have substantially the same fat,...
US20110008325 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid Prepared from a Unit Dose Suspension  
An inhalable unit dose liquid formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The...
US20110028431 ORAL MUCOADHESIVE DOSAGE FORM  
A direct compression formulation suitable for preparing buccal and/or sublingual and dosage forms incorporates a combination of a non-ionic polymeric solubility enhancer, a mucoadhesive polymer, a...
US20120035130 Chirally Correct Retinal Cyclodextrin Acetals for Clarifying Skin Complexion  
The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the...
US20120017924 COATED NICOTINE-CONTAINING CHEWING GUM, MANUFACTURE AND USE THEREOF  
A coated chewing gum product for the delivering of nicotine in any form to a subject by a rapid transmucosal uptake in the oral cavity comprising at least one gum core, nicotine in any form and/or...
US20140378401 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations  
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly...
US20150065457 METHOD OF USING CYCLODEXTRIN  
Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.
US20110305639 METHOD AND FORMULATION FOR REDUCING AGGREGATION OF A MACROMOLECULE UNDER PHYSIOLOGICAL CONDITIONS  
The invention provides a method for reducing aggregation and inhibiting flocculation of a macromolecule, such as a protein, under physiological conditions, by the addition of certain cyclodextrins...
US20140038918 TREATMENTS FOR RETINAL DISORDERS  
The present invention relates to the use of cyclic oligosaccharides as chemical complexants of lipofuscin bisretinoids (A2E) to prevent and treat eye (i.e., retinal or macular) disease. Monomeric,...
US20150209337 NICOTINAMIDE DERIVATE IN THE TREATMENT OF ACUTE CORONARY SYNDROME  
The present invention relates to the use of a nicotinamide derivative in the treatment acute coronary syndrome (ACS) and pharmaceutical compositions used in such treatment.
US20080182821 Anti-Inflammatory and/or Analgesic Composition For the Intestine Comprising Branched Maltodextrins  
The invention concerns a fiber-enriched anti-inflammatory and/or analgesic composition for the intestine, characterized in that it comprises branched maltodextrins having between 15 and 35% of...
US20140206643 PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE  
Provided herein are ready-to-use premixed bolus injection pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and...
US20120214761 PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE  
Provided herein are ready-to-use premixed bolus injection pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and...
US20110028413 Methods of Reducing Methotrexate Nephrotoxicity  
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as methotrexate. The invention provides compositions comprising a substituted...
US20140296180 CYCLIC OLIGOSACCHARIDES FOR USE IN THE TREATMENT AND PREVENTION OF BACTERIAL INFECTION  
Compounds which inhibit Wza-mcdiated polysaccharide transport are useful in the prevention or treatment of bacterial infection, in particular of E. coli infection. The compounds are typically...
US20150202308 BUDESONIDE FORMULATION  
The invention provides budesonide inhalation formulations containing cyclodextrins.
US20120015039 SUSTAINED RELEASE OF NUTRIENTS IN VIVO  
Nutritional compositions delivered in vivo in a time controlled manner sustainable over long periods of time, provide enhancing athletic performance, increased hand/eye coordination and...
US20050171057 Pantoprazole cyclodextrin inclusion complexes  
An inclusion complex formed from pantoprazole and cyclodextrin is described.
US20150018307 DEODORANT COMPOSITIONS  
A deodorant composition contains β-cyclodextrin, a fixative, a preservative, and a solvent.
US20120083467 DEODORANT COMPOSITIONS  
A deodorant composition contains β-cyclodextrin, a fixative, a preservative, and a solvent.
US20110071110 Water Dispersible Policosanol Cyclodextrin Complex and Method of its Production  
Disclosed is a formulation of policosanol with natural cyclodextrins resulting in a water dispersible form of policosanol. The disclosed process provides an economical commercial method for making...
US20150024055 ENHANCED IMMEDIATE RELEASE FORMULATIONS OF TOPIRAMATE  
The present invention provides enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These...
US20120263667 COMPOSITION AND METHOD FOR MODULATING AND MAINTAINING VAGINAL BACTERIAL FLORA AND VAGINAL ACIDITY  
The present invention relates to the use of benzoic acid and/or its sodium salt in combination with saccharide(s) as active components in the manufacture of a vaginal composition for modulating...
US20110251157 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid  
An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can...
US20150216895 CYCLODEXTRIN FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES  
The invention provides for methods of treating lysosomal storage disorders and/or reduction of non-cholesterol lipids, using cyclodextrin compounds, including in combination with other...
US20130202601 ASSAYS, METHODS AND KITS FOR PREDICTING RENAL DISEASE AND PERSONALIZED TREATMENT STRATEGIES  
Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular...
US20150065458 Composition for Inactivating an Enveloped Virus  
The present invention relates generally to the field of prevention of diseases caused by enveloped viruses. More particularly, this invention concerns a composition for inactivating an enveloped...
US20140235574 ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD  
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin...
US20120053145 ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD  
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin...
US20120171282 GINKGO BILOBA EXTRACT WITH A STANDARDISED GINKGO FLAVONE GLYCOSIDES CONTENT DEPRIVED OF THE PAF-ANTAGONIST TERPENIC FRACTION, AND COMPOSITIONS CONTAINING IT, FOR THE PREVENTION AND TREATMENT OF CIRCULATORY, COGNITIVE, GERIATRIC AND SENSORY DISORDERS  
Disclosed is a Ginkgo biloba extract substantially devoid of PAF-antagonist activity.
US20050142123 Water-dispersible coenzyme q10 dry powders  
Novel powder compositions comprising droplets of Coenzyme Q-10 dispersed in a matrix of a modified polysaccharide or a gelatin are obtained by emulsifying Coenzyme Q-10 in a solution of the matrix...
US20130039975 Liposomes Containing Prostaglandin E1 (PGE1), Formulations Containing Them and Their Use  
Unilamellar liposomes comprising PGE1 and/or PGE1-α-cyclodextrin combined with carnitine, in which there are hydrophilic polymers on the external surface of the liposomes are described.
US20130209444 NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES  
The present invention provides non-anticoagulant sulfated or sulfonated polysaccharides (NASPs), which accelerate the blood clotting process. Also provided are pharmaceutical formulations...
US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20070014833 Treatment of eye disorders with sirtuin modulators  
Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from...
US20120077774 COMPOSITIONS AND THEIR USE FOR REMOVING CHOLESTEROL  
The invention is directed to compositions that function to remove cholesterol from a mammal suffering from an elevated cholesterol level. The composition includes a polysaccharide having attached...
US20120156296 ANTIOXIDANTS IN FISH OIL POWDER AND TABLETS  
This invention relates to antioxidants and combinations of antioxidants used to prevent oxidation of pharmaceutical and nutraceutical products in the form of powders, granulates, tablets,...
US20140274949 PERSONAL CARE COMPOSITIONS  
A composition suitable for topical application, for example, is provided. In some examples, the composition can include particular cyclic oligosaccharides, a fragrance, and a volatile solvent. The...
US20110152216 ANAESTHETIC COMPOSITION  
A stable anaesthetic composition is described which is particularly suitable for use in cats and dogs. The composition comprises an aqueous solution of an anaesthetically effective amount of a...
US20120316134 ANAESTHETIC COMPOSITION  
A stable anaesthetic composition is described which is particularly suitable for use in cats and dogs. The composition comprises an aqueous solution of an anaesthetically effective amount of water...
US20110009362 SOLUBILITY-ENHANCED FORMS OF APREPITANT AND PHARMACEUTICAL COMPOSITIONS THEREOF  
Solubility-enhanced forms of aprepitant and processes for preparing such forms. The invention also provides solubility-enhanced forms of aprepitant that also possess stability against solid state...
US20130090371 METHODS AND COMPOSITIONS FOR INHIBITION OF BETA2-ADRENERGIC RECEPTOR DEGRADATION  
The present invention generally relates to compositions and kits comprising a β2-AR agonist and a modulator of a β2-AR regulator gene, where the modulator of the β2-AR regulator gene inhibits the...
US20140171388 COMPOUND FOR TREATING CARTILAGE DISORDERS  
The present invention provides a compound of which active |form| is represented by a formula (A). and which can be injected into a joint cavity which is an affected part of disorders and can be...